On Oct 27, 2021 Immunai closed a Series B round and raised $215,000,000 from 8VC, Alexandria Venture Investments, Icon Ventures, Koch Disruptive Technologies, Piedmont Capital, Talos VC, featuring lead investors Koch Disruptive Technologies.
About the company: Immunai is located at United States, North America.
“”
Company website: http://www.immunai.com